Skip to content

Coronary Disease and the Effect of High-intensity Interval Training

Physical Activity and Lipid Content of Coronary Artery Atheromatous Plaques: a Randomised Trial Using Novel Intracoronary Imaging Techniques

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02494947
Acronym
CENIT
Enrollment
60
Registered
2015-07-10
Start date
2016-02-29
Completion date
2019-04-30
Last updated
2019-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Disease

Keywords

Coronary Angiography, Exercise

Brief summary

The primary purpose of this study is to investigate if systematic, high intensity, interval-based aerobic exercise training results in regression of lipid content of atherosclerotic coronary artery plaques, and in reduction of plaque burden in patients with stable coronary heart disease. Composition and morphologic characteristics of plaques will be studied by intra-coronary near-infrared spectroscopy (NIRS) and intravascular ultrasound (IVUS) in patients undergoing percutaneous coronary intervention.

Interventions

BEHAVIORALhigh intensity interval-based aerobic exercise

Interval exercises done 3 times weekly during 6 months according to standard procedures at the Department of Circulation and Medical Imaging.

OTHERUsual care

Sponsors

St. Olavs Hospital
CollaboratorOTHER
Norwegian University of Science and Technology
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* stable coronary artery disease * will undergo cardiac catheterization * will be treated with percutaneous coronary intervention (PCI) * signed written informed consent * able to execute the intervention

Exclusion criteria

* earlier bypass surgery * known inflammatory disease other than atherosclerosis * planned surgery within 4 months * included in another randomized controlled study

Design outcomes

Primary

MeasureTime frameDescription
lipid content of atherosclerotic coronary artery plaques6 monthsLipid core burden index (LCBI) measured by intracoronary near-infrared spectroscopy

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 12, 2026